Cite
HARVARD Citation
Chen, P. et al. (2020). Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer. Journal for immunotherapy of cancer. 8 (2), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Chen, P. et al. (2020). Galectin-9-based immune risk score model helps to predict relapse in stage I–III small cell lung cancer. Journal for immunotherapy of cancer. 8 (2), p. . [Online].